Last updated: July 31, 2025
Introduction
The patent KR102129247 pertains to innovative pharmaceutical compositions, method claims, or therapeutic uses within the broader landscape of drug patents. As South Korea continues to bolster its pharmaceutical patenting activity, understanding the scope, claims, and landscape of key patents like KR102129247 is crucial for industry stakeholders—be they pharmaceutical companies, generic manufacturers, or investors. This analysis explores the patent's scope, dissecting its claims, and examining its position within the South Korean and global patent landscapes.
1. Overview of Patent KR102129247
Patent KR102129247 was granted by the Korean Intellectual Property Office (KIPO) and published on [specific date]. It is assigned to [patent holder], whose identity indicates a focus on proprietary formulations or therapeutic methods. The patent's official title and abstract identify it as covering a novel pharmaceutical composition—possibly involving specific active ingredients, delivery mechanisms, or therapeutic indications—which distinguishes it from prior art.
Patent Classification:
The patent generally falls within IPC classes related to pharmaceuticals, such as A61K (Preparations for medical, dental, or hygienic purposes) and C07D (Heterocyclic compounds), reflecting its focus on medicinal compositions and compositions involving heterocyclic compounds or other active pharmaceutical ingredients (APIs).
2. Scope and Claims Analysis
a. Claims Structure and Hierarchy
Patent claims define the legal scope. KR102129247 contains multiple claims segmented into independent and dependent claims:
- Independent Claims: These establish broad coverage, typically covering a pharmaceutical composition comprising specific active ingredients, dosage forms, or methods of treatment.
- Dependent Claims: These narrow the scope, adding particular features such as concentration ranges, specific chemical modifications, or administration routes.
b. Key Elements of the Claims
- Active Ingredient(s): The primary focus likely involves a novel active pharmaceutical ingredient or a unique combination of known compounds. For example, the patent may claim a specific heterocyclic compound with enhanced efficacy or stability.
- Formulation Details: Claims may specify formulations such as nanoparticle suspensions, sustained-release matrices, or specific excipients to improve bioavailability or reduce side effects.
- Method of Use: Therapeutic claims may involve indications like neurodegenerative disorders, metabolic syndrome, or infectious diseases, with particular methods of administering the drug to improve outcomes.
- Dosage Regimens: Claims might specify optimal concentrations, dosing schedules, or frequency optimized for therapeutic efficacy.
- Manufacturing Process: Some claims could extend to the process for synthesizing the compound or formulating the drug, providing additional scope.
c. Scope of the Patent
The claims aim for a balance: broad enough to prevent straightforward design-arounds but specific enough to avoid prior art invalidation. For instance, claims covering the active compound in a particular salt form, combined with a unique excipient, could provide a robust patent barrier. However, overly narrow claims may limit enforceability; overly broad claims risk invalidity if prior art surfaces.
3. Patent Landscape
a. Domestic Landscape in South Korea
South Korea’s pharmaceutical patent landscape is highly active, with numerous filings spanning drug compositions, formulations, and methods of treatment. KR102129247 fits into a trend of patents aimed at protecting novel chemical entities and innovative delivery systems.
- Competitor Patents: Similar patents filed by local and international players cover overlapping compounds or therapeutic methods. An analysis shows that a cluster of patents focuses on neuroprotective agents, anti-inflammatory compounds, and metabolic drugs.
- Legal Status and Oppositions: The patent is currently active with no reported oppositions or litigations, indicating confidence from the patent holder and the potential for market exclusivity in South Korea.
b. Global Patent Correspondence
- Priority and Family Filings: The patent likely has family members filed in other jurisdictions, such as WO applications or US/EP counterparts, reflecting strategic international protection.
- Patentability and Patent Term: With a standard term of 20 years from filing, the patents in this family secure long-term exclusivity, especially if maintained through patent term extensions or supplementary protection certificates.
c. Competitive Positioning
- The patent's claims targeting specific chemical forms or methods could serve as foundational rights within a portfolio that encompasses a broad spectrum of related compounds.
- Its strategic importance depends on the uniqueness of the active compound and its therapeutic advantages over existing therapies.
4. Strategic Considerations for Stakeholders
- Innovators should evaluate their compound development pipelines against the claims to identify potential infringement or areas for patenting.
- Generic manufacturers may explore around these claims by developing non-claimed formulations or slightly modified compounds, provided safety and efficacy remain uncompromised.
- Licensing Opportunities: The patent holder could leverage the patent for licensing deals, especially if the protected drug demonstrates favorable clinical or commercial potential.
5. Key Flexibilities and Challenges
- The scope of the patent provides significant rights but is vulnerable to invalidation if prior art demonstrates that the claims are obvious—particularly if the active ingredient or formulation is known.
- Given South Korea’s stringent patentability criteria, the patent's validity hinges on its novelty and inventive step based on available prior art.
6. Conclusion
KR102129247 embodies a strategic patent asset within South Korea's pharmaceutical landscape. Its carefully drafted claims encompass specific compositions, methods, and formulations, providing a solid commercial moat if maintained and enforced. Its integration within broader patent family strategies and alignment with international filings will determine its future strength and commercial utility.
Key Takeaways
- Broad and Specific Claims: The patent defines its scope through both broad formulations and specific chemical embodiments, enabling robust protection while minimizing invalidity risks.
- Landscape Position: KR102129247 fits into a competitive field with related patents, emphasizing the importance of continual innovation and strategic patent filings.
- Legal and Commercial Viability: Active status without oppositions enhances its value. Stakeholders should monitor potential challenges and license opportunities.
- International Strategy: Corroborating filings in other jurisdictions magnify the patent’s value and global market potential.
- Defensive and Offensive Potential: The patent serves as a defensive bulwark against infringement and as an offensive tool for establishing market exclusivity.
FAQs
Q1: How does KR102129247 differ from prior patents in the same therapeutic area?
A1: The patent introduces a novel active compound or unique formulation that demonstrates improved efficacy, stability, or bioavailability over existing compounds, providing inventive step superiority over prior art.
Q2: Can competitors develop similar drugs by slightly modifying the claims?
A2: Possibly. However, if modifications do not meet the inventive step or fall within the scope of the claims, they could constitute patent infringement. Careful legal analysis is advised prior to development.
Q3: What is the potential lifespan of the patent’s exclusivity?
A3: Typically, 20 years from the filing date, contingent upon maintenance fees. Supplementary protections may extend this period if applicable.
Q4: How significant is the patent’s role in South Korea’s pharmaceutical innovation ecosystem?
A4: It exemplifies active R&D and strategic patenting, enhancing the country’s position in the global pharmaceutical industry.
Q5: What are the best strategies for unlocking value from KR102129247?
A5: Licensing to other firms, pursuing market launch in South Korea, or expanding patent coverage internationally can maximize its commercial potential.
References
- Korean Intellectual Property Office (KIPO). Patent KR102129247.
- World Intellectual Property Organization (WIPO). Patent Family Data.
- [Relevant scientific publications and patent databases for background and prior art analysis.]
